Search Results

127,570 Results for "imstem biotechnology".

Sort By

Biotech Bay

AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001

AgeX Therapeutics, Inc. announced today that ImStem Biotechnology, Inc. (“ImStem”), a biopharmaceutical company developing human embryonic stem cell (ESC)-derived mesenchymal stem cells, has dosed the first U.S. multiple sclerosis (MS) patient with ImStem’s lead investigational drug candidate IMS001 at the Shepherd Center in Atlanta, GA.

November 30, 2021
·
6 min read
Layoffs

Sana Biotechnology Will Lay Off Employees as It Shifts Pipeline

About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 diabetes program and looks to extend its cash runway.

November 5, 2024
·
1 min read
·
Angela Gabriel
Press Releases

MAIA Biotechnology to Present at Biotech Showcase 2025

January 10, 2025
·
5 min read
Press Releases

Altimmune Added to Nasdaq Biotechnology Index

December 19, 2024
·
2 min read
Press Releases

Biotechnology and Pharmaceutical Services Outsourcing Market Size, Share & Trends Analysis Report by 2034

January 21, 2025
·
1 min read
Press Releases

Mesoblast to be Added to Nasdaq Biotechnology Index

December 19, 2024
·
5 min read
Press Releases

MindMed to Be Added to the Nasdaq Biotechnology Index

December 19, 2024
·
4 min read
Press Releases

Aramis Biotechnologies and Biodextris Announce Partnership

December 17, 2024
·
2 min read
Press Releases

Puma Biotechnology’s NERLYNX® Included in NCCN Clinical Practice Guidelines for the Treatment of Cervical Cancer with a HER2 Mutation

December 23, 2024
·
8 min read
Press Releases

Biotechnology Market Size to Worth Around USD 3.54 Trillion by 2033

January 8, 2025
·
1 min read